Pharmacist-Led Care Halves Time to Antihypertensive Intensification in Older Ethiopian Adults
This non-randomized cohort suggests pharmacist-led medication review and recommendations can shorten therapeutic inertia in older adults with uncontrolled hypertension, but design limitations constrain causal inference for ambulatory care pharmacists.
📅 Journal publication: Jan-Dec 2026(online May 22, 2026)·Last updated: Nov 17, 2026
Pharmacist-led care cuts hypertension treatment time significantly.
Therapeutic inertia in hypertension management increases cardiovascular risk, especially in older adults in low-resource settings. Pharmacist-led care reduced time to treatment intensification to 28 days compared to 63 days in usual care. This study demonstrates that pharmacist interventions can accelerate treatment adjustments and improve hypertension outcomes in resource-limited settings. Applicability may vary due to geographical and systemic differences. Pharmacist-led interventions expedite hypertension treatment adjustments, enhancing blood pressure control.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Dagnew SB, Zerihun TE, Mussie DA, Moges TA, Wondm SA, Bayafers Tamene F, Tarekegn GY, Zewdu WS, Kassaw AT
Citation:Dagnew SB, Zerihun TE, Mussie DA, et al. Improving timeliness of antihypertensive treatment intensification through pharmacist-led interventions among older adult patients in Northwest Ethiopia: Multicenter prospective cohort study. Sage open chronic disease. 2026;17:27558428261452289. doi:10.1177/27558428261452289